India APAC
FDF / DRUG PRODUCTS CHEMICAL-SYNTHETIC in APAC
Pharmaceutical Intermediate and API manufacturing company. WHO GMP accredited and also hold EU Written confirmation
About the plant
Unimax Chemicals Pvt Ltd is pharmaceutical intermediate and API manufacturing plant incepted in 1985.
WHO-GMP Accredited and also hold EU Written confirmation
API Registered in Russia, Japan
Annual Production Capacity - 350MT
Compliance
- World Health Organization (GMP / HACCP)
Activity
- Oral solids / OSD, Topical, mucosal and transdermal, Powders, FDF / DRUG PRODUCTS, CHEMICAL-SYNTHETIC, Intermediates, API (Active Pharmaceutical Ingredients) manufacturing
Features
- Uses: Commercial (Phase IV), Human, Veterinary
- Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day)
- Controlled substance: Low potential for abuse, Lowest potential for abuse
- BSL: N/A
- Therapeutic areas: (D) Dermatologicals, (J) Antiinfectives for systemic use, (N) Nervous system
- Markets: PMDA (Japan), CDSCO (India), Russian Health Authorities
Batch Size / Reactor
- Small, Medium, Large, 2,000 - 5,000 L
Services
- Manufacturing services, Engineering batches, Scale-up, Pilot batches, Batch records, Clean room rental, Milling
